Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 

With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.

Scientists are trying to design the last malaria control agent the world will ever need.

Bacteria that live in the digestive tracts of animals may influence the adaptive trajectories of their hosts.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

Bacteria inhabit most tissues in the human body, and genes from some of these microbes have made their way to the human genome. Could this genetic transfer contribute to diseases such as cancer?

Bats harbor diverse pathogens, including Ebola, Marburg, SARS, and MERS viruses. Understanding why could help researchers stymie deadly emerging diseases.

Photo: Steve Waldhauser SCIENCE IN PUBLIC: Almost 6,000 people attended the Nobel Conference, showing a high degree of public interest in science. When a group of leading virus researchers and scholars presented their reports on "Virus: The Human Connection" at the annual Nobel Conference in St. Peter, Minn., last month, the story that emerged was one of war and peace. The primary themes emanating from these talks--which were open to the public--outlined a heavy viral volume of battles won and